Clover Health Investments Other Share Holders Equity 2020-2025 | CLOV

Clover Health Investments other share holders equity from 2020 to 2025. Other share holders equity can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Clover Health Investments Annual Other Share Holders Equity
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
Clover Health Investments Quarterly Other Share Holders Equity
(Millions of US $)
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.517B $1.371B
Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.644B 58.07
Doximity (DOCS) United States $11.655B 53.96
Hims & Hers Health (HIMS) United States $11.295B 117.35
Tempus AI (TEM) United States $9.675B 0.00
IRhythm Technologies (IRTC) United States $4.275B 0.00
Inspire Medical Systems (INSP) United States $3.775B 58.99
Hinge Health (HNGE) United States $3.572B 0.00
Privia Health (PRVA) United States $2.516B 172.00
Enovis (ENOV) United States $1.765B 9.84
Phreesia (PHR) United States $1.591B 0.00
10x Genomics (TXG) United States $1.505B 0.00
Schrodinger (SDGR) United States $1.495B 0.00
Azenta (AZTA) United States $1.461B 67.89
Evolent Health (EVH) United States $1.335B 113.70
Omnicell (OMCL) United States $1.276B 22.51
Claritev (CTEV) United States $0.717B 0.00
Fulgent Genetics (FLGT) United States $0.550B 0.00
Veradigm (MDRX) United States $0.536B 0.00
Standard BioTools (LAB) United States $0.463B 0.00
Butterfly Network (BFLY) United States $0.435B 0.00
Talkspace (TALK) United States $0.420B 125.50
TruBridge (TBRG) United States $0.321B 713.00
Outset Medical (OM) United States $0.320B 0.00
Nyxoah SA (NYXH) Belgium $0.270B 0.00
Health Catalyst (HCAT) United States $0.260B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.231B 0.00
CapsoVision (CV) United States $0.213B 0.00
Zepp Health (ZEPP) Netherlands $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.136B 0.00
American Well (AMWL) United States $0.125B 0.00
EUDA Health Holdings (EUDA) Singapore $0.120B 0.00
Pulmonx (LUNG) United States $0.109B 0.00
MDxHealth SA (MDXH) Belgium $0.103B 0.00
CareCloud (CCLD) United States $0.098B 3.73
ImmunoPrecise Antibodies (IPA) Canada $0.083B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.080B 0.00
111 (YI) China $0.064B 0.00
P3 Health Partners (PIII) United States $0.046B 0.00
HeartBeam (BEAT) United States $0.042B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00